ArticleScientific reports2022

Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide.

Caryn E Plummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.